Opening Keynote: Sensitivity and Resistance to I-O: Biological Insights and their Translation into Precision Treatment* 

Naiyer Rizvi, Professor, Director of Thoracic Oncology and Director of Immunotherapeutics for the Division of Hematology and Oncology, Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, USA